Significant Ownership of Sofinnova Crossover I
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Sofinnova Crossover I focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Antoine Papiernik - Authorized Representative
- Manager location
- Paris, France
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Sofinnova Crossover I with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Sofinnova Crossover I
Significant Ownership of Sofinnova Crossover I
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IVA | Inventiva, S.A. | Ordinary Shares, nominal value EUR0.01 per share | 8.6% | $108,981,346 | +$64,487,273 | 19,086,050 | +145% | Sofinnova Partners SAS, a French corporation | 31 Dec 2025 |
| ABVX | Abivax S.A. | Ordinary Shares, par value EUR0.01 per share | 4.3% | $471,190,328 | -$261,676,160 | 3,535,843 | -36% | Sofinnova Crossover I SLP | 02 Jul 2026 |
Schedules 13D/G Reported by Sofinnova Crossover I:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.